Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2007-08-02

Original market date: See footnote 1

1996-02-02

Product name:

2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE QUICKMIX

DIN:

02014009 Electronic product monograph is not available

Company:

BAXTER CORPORATION CLINTEC NUTRITION DIVISION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

19

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

40:20.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05BA10 COMBINATIONS

Active ingredient group (AIG) number:See footnote5

1950854014

List of active ingredient(s)
Active ingredient(s) Strength
DEXTROSE 25 G / 100 ML
GLYCINE 570 MG / 100 ML
HISTIDINE 120.5 MG / 100 ML
L-ALANINE 570 MG / 100 ML
L-ARGININE 285 MG / 100 ML
L-ISOLEUCINE 131.5 MG / 100 ML
L-LEUCINE HYDROCHLORIDE 170 MG / 100 ML
L-LYSINE HYDROCHLORIDE 159 MG / 100 ML
L-PHENYLALANINE HYDROCHLORIDE 170 MG / 100 ML
L-PROLINE 115 MG / 100 ML
L-THREONINE 115 MG / 100 ML
L-TYROSINE 11 MG / 100 ML
L-VALINE 126 MG / 100 ML
MAGNESIUM CHLORIDE 51 MG / 100 ML
METHIONINE 159 MG / 100 ML
POTASSIUM PHOSPHATE DIBASIC 261 MG / 100 ML
SODIUM ACETATE 215.5 MG / 100 ML
SODIUM CHLORIDE 112 MG / 100 ML
TRYPTOPHAN 49.5 MG / 100 ML
Version 4.0.2
Date modified: